Dear John,

Join us tomorrow for a free live taping of A Health Podyssey where Jennifer Kao will discuss her paper exploring the impact of risk evaluation and mitigation strategies on generic approvals of US pharmaceutical products.

Today's Featured Articles

Hospital– And Private Equity–Affiliated Specialty Physicians Negotiate Higher Prices Than Independent Physicians

Alexander P. Philips et al.

What Might Happen If MA Shifted Certain Drugs From Part B To Part D?

Dori Reyneri

part of our Assessing The Evidence For MA Reform series

FDA Vaccine Suspensions: Outliers Or The New Normal?

Richard Hughes IV and William Walters

More from Assessing The Evidence For MA Reform series

Step Therapy In MA: Mixed Evidence And An Uncertain Path Forward

G. Caleb Alexander

What Drives Beneficiaries To Switch Between MA And FFS Plans?

William V. Padula

The Different Costs — and Sites — of Care for Commercial Insurers w/ Matthew Maughan

Health Affairs' Rob Lott interviews Matthew Maughan of Brown University about his paper exploring how commercial insurers paid more for procedures at hospital outpatient departments as compared to ambulatory surgical centers.

Health Benefits in 2025: Insights from the KFF Employer Health Benefits Survey

Join Health Affairs and KFF’s Matthew Rae on November 5 for an exclusive Insider virtual event exploring the findings from the KFF Employer Health Benefits Survey, reporting on benefits in 2025.